Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Events

Events

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • Cannabis
  • Entrepreneurship
  • Events
  • General
  • Markets
  • News
  • Penny Stocks
  • Small Cap

Cannabis vs. Tobacco: The Battle For Market Share And Public Health

By Jelena Martinovic
March 31, 9:49 AM
A recent poll showed that Americans prefer legal cannabis over legal tobacco.

BTI

Read More
3 minute read
  • Biotech
  • Events
  • FDA
  • General
  • News

Prothena Presents New Preclinical Data Supporting Best-In-Class Profile Of PRX012, A Next-Generation Anti-Amyloid Beta Antibody, At AD/PD 2023

By Happy Mohamed
March 31, 9:20 AM
Data from oral presentation adds to growing body of evidence supporting the profile of PRX012, which is designed to target all aggregated forms of amyloid beta with high binding potency Demonstrated 20-fold higher

PRTA

Read More
2 minute read
  • Events
  • News

Reported Late Thursday March 30, Australian Prime Minister Anthony Albanese Visits Tritium At The Company’s Campus In Brisbane, Australia

By Happy Mohamed
March 31, 12:26 AM
 Tritium DCFC Limited (Tritium) (NASDAQ:DCFC), a global leader in direct current (DC) fast chargers for electric vehicles (EVs), welcomed Australian Prime Minister Anthony Albanese to the company's campus in

DCFC

Read More
2 minute read
  • Biotech
  • Events
  • General
  • News

GeoVax To Participate At The World Vaccine Congress With Multiple Presentations; New Data From The Ongoing Phase 2 Trial Of GEO-CM04S1 To Be Presented

By Happy Mohamed
March 30, 11:01 AM
New data from the ongoing Phase 2 trial of GEO-CM04S1 to be presented   Atlanta, GA, March 30, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (NASDAQ:GOVX), a biotechnology company

GOVX

Read More
2 minute read
  • Events
  • News

HeartCore Integrates ChatGPT Into HeartCore CMS For Automated Content Creation

By Happy Mohamed
March 30, 8:47 AM
HeartCore Enterprises, Inc. ("HeartCore" or the "Company"), a leading software development company offering Customer Experience Management Platform ("CXM Platform") and Digital

HTCR

Read More
3 minute read
  • Biotech
  • Events
  • FDA
  • General
  • News

Jaguar Animal Health Exhibiting At Veterinary Cancer Society Collaborative Conference For Canalevia-CA1, The Company’s FDA Conditionally Approved Drug For Chemotherapy-Induced Diarrhea In Dogs

By Happy Mohamed
March 30, 8:35 AM
Canalevia®-CA1 is the first and only treatment for CID in dogs to receive any type of approval from the FDA In December 2022, FDA increased the maximum number of dogs that can be treated annually with a

JAGX

Read More
2 minute read
  • Events
  • Gaming
  • General
  • News

E3’s Future Uncertain As More Publishers Pull Out: Sega, Tencent and Ubisoft Latest To Drop

By Franca Quarneti
March 29, 2:50 PM
There is growing concern over the future of E3, the largest video game conference and trade show in the world, as more publishers pull out behind Nintendo ADR (OTC:

MSFT

Read More
2 minute read
  • Events
  • News

Apple’s Worldwide Developers Conference Returns June 5, 2023

By Happy Mohamed
March 29, 2:07 PM
Entire conference available online for all developers, with a special in-person experience at Apple Park on June 5 Submissions for the Swift Student Challenge are open now through April 19 Apple® today announced it

AAPL

Read More
2 minute read
  • Cannabis
  • Events
  • Markets
  • News

Traditional Retail: Have You Heard Of The Cannabis Margin Booster?

By Nicolas Jose Rodriguez
March 29, 9:05 AM
The cannabis industry has evolved from medical use to include consumer packaged goods (CPG) made of hemp and containing THC or CBD.

AMZN

Read More
2 minute read
  • Biotech
  • Events
  • FDA
  • General
  • News

Gain Therapeutics To Present Preclinical Data On Its GBA1 Program At The AD/PD 2023 Meeting March 28 – April 1, 2023 In Gothenburg, Sweden

By Happy Mohamed
March 29, 8:55 AM
Gain Therapeutics, Inc. (NASDAQ:GANX) ("Gain", or the "Company"), a biotechnology company leading the discovery and development of allosteric small molecule therapies, today announced the presentation

GANX

Posts pagination

Previous 1 … 80 81 82 … 128 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service